Lyons, France

Martina Ochs-Onolemhemhen

USPTO Granted Patents = 5 


Average Co-Inventor Count = 3.8

ph-index = 2

Forward Citations = 9(Granted Patents)


Company Filing History:


Years Active: 2013-2017

Loading Chart...
Loading Chart...
5 patents (USPTO):Explore Patents

Title: Martina Ochs-Onolemhemhen: Innovator in Immunogenic Compositions

Introduction

Martina Ochs-Onolemhemhen is a prominent inventor based in Lyons, France. She has made significant contributions to the field of immunology, particularly in the development of immunogenic compositions. With a total of 5 patents to her name, her work has the potential to impact public health positively.

Latest Patents

Her latest patents include innovative immunogenic compositions that utilize adjuvants for enhancing the efficacy of vaccines. One notable patent focuses on adjuvants that comprise aluminum compounds treated with various compounds such as phosphate and sulfate. This advancement aims to improve methods for preventing and treating diseases. Another significant patent involves immunogenic compositions that include mutant pneumolysin (PLY) proteins, along with the nucleic acids and polypeptides encoded by them. These compositions are designed for various applications in immunology.

Career Highlights

Martina has worked with notable organizations, including Sanofi Pasteur Inc. and the National Institute of Public Health and the Environment in the Netherlands. Her experience in these institutions has allowed her to contribute to groundbreaking research and development in the field of immunology.

Collaborations

Throughout her career, Martina has collaborated with esteemed colleagues such as Eliud Oloo and Raymond Oomen. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.

Conclusion

Martina Ochs-Onolemhemhen is a trailblazer in the field of immunogenic compositions, with a focus on enhancing vaccine efficacy. Her contributions through her patents and collaborations highlight her commitment to advancing public health.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…